Rite Aid is reportedly planning to file for bankruptcy to address federal and state lawsuits it is facing over its alleged role in the sale of opioids, per a WSJ report.
Roche’s Columvi is the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma.